ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø

Àü¹®¼¾ÅÍ ¾Ï¼¾ÅÍ
Áø·á°ú ¿Ü°ú HOME

Àü¹®Áø·áºÐ¾ß

À¯¹æ¾Ï, À¯¹æÁúȯ

ÀüÈ­ ¿¹¾à 1522-2500

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-11-25 ~ 2024-11-30)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á¿Ü·¡Áø·á

ÇзÂ

ÇзÂ

1991¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷

2000¼­¿ï´ëÇб³ ´ëÇпø ÀÇÇÐ ¼®»ç

2007¼­¿ï´ëÇб³ ´ëÇпø ÀÇÇÐ ¹Ú»ç

°æ·Â

°æ·Â

1991 ~ 1996¼­¿ï´ëÇб³º´¿ø ¼ö·Ã/¿Ü°ú Àü°øÀÇ ¼ö·á

1996 ~ 1999¼­¿ï±¹±ºÁö±¸º´¿ø ¿Ü°ú ±ºÀÇ°ü

1999 ~ 2001¼­¿ï´ëÇб³º´¿ø À¯¹æ³»ºÐºñ¿Ü°ú ÀüÀÓÀÇ

2001 ~ 2003¼­¿ï¾Æ»êº´¿ø À¯¹æ³»ºÐºñ¿Ü°ú ÀüÀÓÀÇ

2012 ~ 2014ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ±âȹ½ÇÀå ¿ªÀÓ

2015 ~ 2016Research Scholar, Division of Endocrinology, Metabolism, and Diabetes, Molecular Medicine, National Mouse Metabolic Phenotyping Center, University of Massachusetts Medical School, USA

ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø À¯¹æ³»ºÐºñ¿Ü°ú ±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

Çѱ¹À¯¹æ¾ÏÇÐȸ ÀÓ»ó½ÃÇè À§¿øȸ À§¿ø ¿ªÀÓ

´ëÇÑÀÓ»óÁ¾¾çÇÐȸ ÀÓ»ó½ÃÇè À§¿øȸ À§¿ø ¿ªÀÓ

´ëÇÑÀÓ»óÁ¾¾çÇÐȸ °í½ÃÀ§¿øȸ À§¿ø ¿ªÀÓ

´ëÇÑ¿Ü°úÇÐȸÁö ³í¹®½É»çÀ§¿ø

Breast Cancer Research and Treatment ³í¹®½É»çÀ§¿ø

Çѱ¹À¯¹æ¾ÏÇÐȸ Åë°èÀ§¿øȸ À§¿ø ¿ªÀÓ

¹Ì±¹¾ÏÇÐȸ (American Association for Cancer Research) Á¤È¸¿ø(active member)

Çѱ¹À¯¹æ¾ÏÇÐȸ Æò»ýȸ¿ø ¹× À¯¹æ ÀÎÁ¤ÀÇ

´ëÇÑÀÓ»óÁ¾¾çÇÐȸ Æò»ýȸ¿ø ¹× ´ëÇÑ ÀÓ»óÁ¾¾ç ÀÎÁ¤ÀÇ

Çѱ¹À¯¹æ¾ÏÇÐȸ Áø·á±Ç°í¾È À§¿øȸ À§¿ø ¿ªÀÓ

³í¹®/Àú¼­

³í¹®/Àú¼­
±¹³»ÇÐȸÁö ¹ßÇ¥³í¹®
1. À¯¹æ¾Ï¿¡¼­ Mammaglobin ¿ªÀü»ç-ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀÀ» ÀÌ¿ëÇÑ ¸²ÇÁÀý ¹Ì¼¼ÀüÀÌÀÇ °Ë»ö. ´ëÇÑ¿Ü°úÇÐȸÁö 2000;59(6) °­ÈñÁØ, ±è¼º¿ø, À̷ɾÆ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

2. À¯¹æ ÀýÁ¦¼ú ÈÄÀÇ Áï½Ã À¯¹æÀç°Ç¼ú. ´ëÇÑ¿Ü°úÇÐȸÁö 2000;59(5) °­ÈñÁØ, ±è¼º¿ø, ³ëµ¿¿µ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ÇÑ»ó¹é, ¹Î°æ¿ø

3. À¯¹æ¿±»óÁ¾¾çÀÇ ÀÓ»óÀû °íÂû. ´ëÇÑ¿Ü°úÇÐȸÁö 2000;58(3) ±èÈñÁ¤, ±èż±, °­ÈñÁØ, Á¶ÇâÁ¤, ¹ÚÀξÖ, ³ëµ¿¿µ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø

4. RidolfiÀÇ Áø´Ü±âÁØ¿¡ ÀÇÇÑ ¼öÁú¼º À¯¹æ¾ÏÀÇ º´¸®ÇÐÀû ÀçºÐ·ù. ´ëÇÑ¿Ü°úÇÐȸÁö 2000;59(3) ±è¼º¿ø, ¹ÚÀξÖ, Àå¸íö, °­ÈñÁØ, ³ëµ¿¿µ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø

5. Çѱ¹ÀÎ ¾ç¼º À¯¹æÁúȯÀÇ À§Çè¿äÀο¡ ´ëÇÑ È¯ÀÚ-´ëÁ¶±º ¿¬±¸. Çѱ¹¿ªÇÐȸÁö 2000;22(1) ¹Ú¼ö°æ, À¯±Ù¿µ, °­´ëÈñ, ±è¼÷¾ð, ÀÌ»óÀ±, ÀÓÇüÁØ, °­ÈñÁØ, ³ëµ¿¿µ, ÃÖ±¹Áø

6. ħÀ±¼º À¯¹æ¾Ï°ú ¼öÁú¼º À¯¹æ¾ÏÀÇ ¿¹ÈÄÀÎÀÚ ºñ±³. ´ëÇÑ¿Ü°úÇÐȸÁö 2000;59(3) ±è¼º¿ø, °­ÈñÁØ, ³ëµ¿¿µ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø

7. ħÀ±¼º À¯¹æ¾Ï¿¡¼­ p53, C-erbB2, bcl-2, Cathepsin D ¹ßÇöÀÇ ÀÇÀÇ. ´ëÇÑ¿Ü°úÇÐȸÁö 2001;60(6) °­ÈñÁØ, ±è¼º¿ø, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

8. À¯¹æ¾Ï¿¡¼­ °¨¸¶ ŽħÀÚ¸¦ ÀÌ¿ëÇÑ °¨½Ã¸²ÇÁÀý »ý°Ë. ´ëÇÑ¿Ü°úÇÐȸÁö 2001;60(5) ±è¼º¿ø, °­ÈñÁØ, Á¤±â¿í, ±èÈñÁ¤, °íâ´ë, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

9.ÀӽŰú °ü·ÃµÈ À¯¹æ¾Ï. ´ëÇÑ¿Ü°úÇÐȸÁö 2001;60(4) °­¼¼ÈÆ, ±è¼º¿ø, °­ÈñÁØ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

10. À¯¹æ¾Ï¿¡¼­ MIB1 (Ki-67) Labeling index ¿¬±¸¿Í ´Ù¸¥ ¿¹ÈÄÀÎÀÚµé°úÀÇ ¿¬°ü¼º ºñ±³. ´ëÇÑ¿Ü°úÇÐȸÁö 2001;60(4) °íâ´ë, °­ÈñÁØ, ±è¼º¿ø, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

11. À¯¹æ¾Ï¿¡¼­ ¾×¿Í ¸²ÇÁÀý ¹Ì¼¼ÀüÀÌÀÇ Áø´ÜÀ» À§ÇÑ ¿ªÀü»ç ÁßÇÕÈ¿¼Ò¹ÝÀÀÀÇ ÀÇÀÇ; MUC1, Cytokeratin19ÀÇ °á°ú ºñ±³. ´ëÇÑ¿Ü°úÇÐȸÁö 2001;60(1) À̷ɾÆ, °­ÈñÁØ, ±è¼º¿ø, °­ÇѼº, ±è¼º¼÷, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

12. È­»ý¼º À¯¹æ¾ÏÀÇ ÀÓ»ó ¹× º´¸®ÇÐÀû Ư¼º. ´ëÇÑ¿Ü°úÇÐȸÁö 2001;60(3) ±è¼º¿ø, °­ÈñÁØ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

13. À¯¹æ¾Ï °¨½Ã¸²ÇÁÀý¿¡¼­ ¹Ì¼¼ÀüÀÌ¿¡ °üÇÑ ¿¬±¸. ´ëÇÑ¿Ü°úÇÐȸÁö 2001;60(2) ±è¼º¿ø, ¹Ú¼º½Å, ¾È¼öÁ¤, °­ÈñÁØ, À±¿©±Ô, ¿À½Â±Ù, ÃÖ±¹Áø, ³ëµ¿¿µ

14. À¯¹æÇÐ Á¦2ÆÇ ÀÏÁ¶°¢, 2007 ¾ç¼ºÀ¯¹æÁúȯ °­ÈñÁØ. ±¸¹üȯ, ±è±Çõ, ±èµ¿¼®, ±èÀ¯»ç, ±èÀ̼ö, ±èÀÎö, ±èÁ¤¼ö, ¹Ú¼ºÁØ, ¹Ú¼ºÈ¯, ¹Ú¿ë·¡, ¹è¿ø±æ, À±Á¤ÇÑ, ÀÌ°æÆ÷, ÀÌÀ纹, Á¦°¥¿µÁ¾

15. ¾Ï¼ºÇÇ·ÎÀÇ Ä¡·á. ´ëÇÑÀÓ»óÁ¾¾çÇÐȸÁö 2007;3(1) °­ÈñÁØ, ±èÀ̼ö


±¹Á¦ÇÐȸÁö ¹ßÇ¥³í¹®
SCI / SCIE

1. PI 3-kinase Mutation Linked to Insulin and Growth Factor Resistance in vivo. Jonathon N. Winnay, Marie H. Solheim, Ercument Dirice, Masaji Sakaguchi, Hye-Lim Noh, Hee Joon Kang, Hirokazu Takahashi, Kishan Kumar Chudasama, Jason K. Kim, Anders Molven, C. Ronald Kahn and Pål R. Nj©ªlstad. J Clin Invest. 2016 126(4):1401-12.

2. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Yim, Dong-Seok; Park, Sue Kyung; Yoo, Keun-Young; Yoon, Kyung-Sik; Chung, Hwyoung Hwa; Kang, Hee Joon; Ahn, Se-Hyun; Noh, Dong-Young; Choe, Kuk-Jin; Jang, In-Jin. Pharmacogenetics and Genomics 2001 11(4) 279-286

3. Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Kang, Hee-Joon; Kim, Sung-Won; Kim, Hee Joung; Ahn, Soo-Jung; Bae, Ji-Yeon; Park, Sue Kyung; Kang, Daehee; Hirvonen, Ari; Choe, Kuk Jin; Noh, Dong-Young. Cancer Letters 2002 178(2) 175-180

4. Curcumin Suppresses the Paclitaxel‐Induced Nuclear Factor‐¥êB in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model. Kang, Hee Joon; Lee, Sang Hun; Price, Janet E; Kim, Lee Su. The breast journal 2009 15(3) 223-229

5. The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium. Ko, Chang Dae; Kim, Jee Soo; Ko, Byung Gyun; Son, Byung Ho; Kang, Hee Joon; Yoon, Ho Sung; Cho, Eun Yoon; Gong, Gyungyub; Ahn, Sei Hyun. Clinical & experimental metastasis 2003 7(20) 593-597

6. Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals. Kang, Hee Joon; Youn, Yeo-Kyu; Hong, Mi-Kyoung; Kim, Lee Su. Journal of Korean medical science 2011 26(7) 893-899

7. ¥áB-Crystallin is a novel oncoprotein associated with poor prognosis in breast cancer. Kim, Hae Sung; Lee, Younok; Lim, Young Ah; Kang, Hee Joon; Kim, Lee Su. Journal of Breast Cancer 2011 14(1) 14-19

8. The use of a corrective procedure with Vicryl mesh for oncoplastic surgery of the breast. Eom, Tae Ik; Kim, Byung Seup; Koo, Bon Young; Kim, Jong Wan; Lim, Young Ah; Lee, Han Hee; Lee, Su Jung; Kang, Hee Joon; Kim, Lee Su. Journal of Breast Cancer 2009 12(1) 36-40

9. The reliability of histoculture drug response assay (HDRA) in chemosensitivity tests for breast cancer. Kang, Hee Joon; Ko, Chang Dae; Yoon, Ho Sung; Kim, Moon Bo; Ahn, Sei Hyun. Cancer Res Treat 2001 33 392-397

10. Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis. Seok, Jeong-Ho; Kim, Lee Su; Hong, Narei; Hong, Hyun Ju; Kim, Su-Jin; Kang, Hee Joon; Jon, Duk-In. General hospital psychiatry 2010 32(5) 503-508

11. Expression of p53, c-erbB2, bcl-2, Cathepsin D in Infiltrating Ductal Cancer of the Breast. Kang, Hee Joon; Kim, Sung Won; Yun, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of Korean Breast Cancer Society 2001 4(2) 144-151

12. The number of removed lymph nodes for an acceptable false negative rate in sentinel lymph node biopsy for breast cancer. Koo, Bon Young; Jeong, Seong Gu; Eom, Tae Ik; Kang, Hee Joon; Kim, Lee Su. Journal of Breast Cancer 2009 12(2) 100-105

13. The role of heat shock protein 90/70 as potential molecular therapeutic targets in breast cancer. Kim, Lee-Su; Lee, Hwa Seon; Choi, Jin Wook; Kang, Hee Joon; Price, Janet E. Cancer Research 2005 65(9 Supplement) 551-551

14. Clinical analysis of phyllodes tumor of the breast. Kim, Hee Joung; Kim, Tae Seon; Kang, Hee Joon; Cho, Hang Joung; Park, In; Noh, Dong Young; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin. Journal of the Korean Surgical Society 2000 58(3) 352-360

15. Immediate breast reconstruction after a mastectomy for breast cancer . Kang, Hee Joon; Kim, Sung Won; Noh, Dong Young; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Han, Sang Baek; Minn, Kyung Won. Journal of the Korean Surgical Society 2000 59(5) 584-589

16. Comparison of the prognostic factors between medullary cancer and infiltrating ductal carcinoma in the breast. Kim, Sung Won; Kang, Hee Joon; Noh, Dong Young; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin. Journal of Korean Breast Cancer Society 2000 3(2) 85-94

17. Assessment of MIB1 (Ki-67) Labeling Index and Correlation with Other Well Established Prognostic Factors in Breast Cancer. Ko, Chang Dae; Kang, Hee Joon; Kim, Sung Won; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of the Korean Surgical Society 2001 60(4) 361-367

18. Survival analysis and its prognostic factors after distant relapse in breast cancer patients. Yoon, Ho Sung; Kang, Hee Joon; Xu, Xuejun; Ahn, Sei Hyun. Journal of the Korean Surgical Society 2003 64(2) 101-108

19. Pathologic findings of residual tumor according to the response rate after neoadjuvant chemotherapy for breast cancer. Kim, Jong Wan; Jung, Sung Ku; Eum, Taeik; Koo, Bon Young; Kang, Hee Joon; Kim, Lee Su. Journal of the Korean Surgical Society 2008 75(1) 1-8

20. The role of heat shock proteins 70/90 as potential molecular therapeutic targets in breast cancer. Kang, Hee Joon; Hong, Mi-Kyoung; Jung, Sung Ku; Kim, Lee Su. Journal of Breast Cancer 2007 10(4) 231-240

21. Correlation of immunohistochemical expression of MDR1, MRP1, topoisomerase IIalpha with prognostic factors and histoculture drug response assay (HDRA) result in breast carcinoma. Kang, Hee Joon; Hong, Sung Hee; Son, Byung Ho; Yoon, Ho Sung; Gong, Gyung Yub; Ahn, Sei Hyun. Journal of Korean Breast Cancer Society 2004 7(4) 228-235

22. Medullary Carcinoma of the Breast Reclassification by Ridolfi's criteria. Kim, Sung Won; Park, In; Chang, Myung Chul; Kang, Hee Joon; Noh, Dong Young; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin. Journal of the Korean Surgical Society 2000 59(3) 298-304

23. Bfl-1 gene expression in breast cancer: its relationship with other prognostic factors. Yoon, Ho-Sung; Hong, Sung-Hee; Kang, Hee-Jun; Ko, Byung Kyun; Ahn, Sei-Hyun; Huh, Joo-Ryung. Journal of Korean medical science 2003 18(2) 225-230

24. Pattern of secondary failure and prognostic factors for survival following surgical treatment of isolated locoregional recurrence after mastectomy of breast cancer. Son, Byung Ho; Hong, Sung Hee; Kang, Hee Jun; Yoon, Ho Sung; Ahn, Sei Hyun. Journal of the Korean Surgical Society 2003 64(4) 282-288

25. Detection of Axillary Lymph Node Micrometastasis using RT-PRC Comparison the results of MUC1, Cytokeratin 19. Lee, Ryung Ah; Kang, Han Sung; Kang, Hee Joon; Kim, Tae Seon; Kim, Seong Suk; Noh, Dong Young; Choe, Kuk Jin. Journal of Korean Breast Cancer Society 1999 2(2) 128-137

26. Detection of Micrometastasis in Peripheral Blood of Breast Cancer Patients Using RT-PCR Assay: Comparison of MUC1, CK19 and hMMG. Kang, Hee Joon; Hong, Sung Hee; Yoon, Ho Sung; Ahn, Sei Hyun. Journal of Korean Breast Cancer Society 2002 5(4) 298-304

27. Detection of lymph node micrometastases in breast cancer by using mammaglobin mRNA RT-PCR. Kang, Hee Joon; Kim, Sung Won; Lee, Ryung Ah; Yun, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of the Korean Surgical Society 2000 59(6) 709-719

28. Detection of Axillary Lymph Node Micrometastases in Breast Cancer Using RT-PCR: Comparison the Results of MUC1, Cytokeratin 19. Lee, Ryung Ah; Kang, Hee Joon; Kim, Sung Won; Kang, Han Sung; Kim, Seong Suk; Yun, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of the Korean Surgical Society 2001 60(1) 29-35

29. Detection of Axillary Lymph Node Micrometastases in Breast Cancer Using RT-PCR Comparison the Results of MUC1, Cytokeratin 19. Lee, Ryung Ah; Kang, Hee Joon; Kim, Sung Won; Kang, Han Sung; Kim, Seong Suk; Yun, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of Korean Breast Cancer Society 2002 5(2) 154-160

30. Detection of Breast Cancer Micrometastases in Sentinel Lymph Nodes. Kim, Sung Won; Park, Sung Shin; Ahn, Soo Jung; Kang, Hee Joon; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young Journal of Korean Breast Cancer Society 2002 5(2) 161-167

31. Detection of Breast Cancer Micrometastases in Sentinel Lymph Nodes. Kim, Sung Won; Park, Sung Shin; Ahn, Soo Jung; Kang, Hee Joon; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of the Korean Surgical Society 2001 60(2) 154-160

32. The clinicopathologic characteristics of metaplastic carcinomas of the breast. Kim, Sung Won; Kang, Hee Joon; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of the Korean Surgical Society 2001 60(3) 251-255

33. Sentinel Node Biopsy in Breast Cancer Using a Gamma-detection Probe. Kim, Sung Won; Kang, Hee Joon; Chung, Ki Wook; Kim, Hee Joung; Ko, Chang Dae; Youn, Yeo Kyu; Oh, Seung Keun; Choe, Kuk Jin; Noh, Dong Young. Journal of the Korean Surgical Society 2001 60(5) 483-489

34. Comparison of validation in predicting sentinel and non-sentinel lymph node metastasis by prediction models for axillary lymph node metastasis in breast cancer patients . Han, Sang Hyup; Kim, Hae Sung; Kim, Jun Ho; Lee, Youn Ok; Lim, Young Ah; Kang, Hee Joon; Kim, Lee Su. Korean Journal of Clinical Oncology 2012 8(2) 70-78

35. Expression of c-met Gene in Thyroid Tumors. Cha, Hee Jeong; Cho, Seong Jin; Yoo, Chong Woo; Chang, Wu Young; Kang, Hee Joon; Joo, Sun Hyung; Park, Chan Heun; Park, Cheol Jae. Journal of the Korean Surgical Society 2004 67(4) 279-285

36. Clinical Significance of the Ki-67 Index for Colorectal Cancer. Yang, Hyeong Tae; Yoon, Dae Kun; Jang, Woo Young; Choi, Gyu Seong; Kang, Hee Jun; Cheon, Seong Eun; Park, Sung Gil; Kim, Jong Hyun; Chun, Wook; Hun, Jun. Journal of the Korean Surgical Society 2007 72(4) 297-301

37. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival. Lee, Jung Ah; Kim, Kwan-Il; Bae, Jeoung Won; Jung, Young-Hoon; An, Hyonggin; Lee, Eun Sook; Society, Korean Breast Cancer (Kang, Hee Joon). Breast cancer research and treatment 2010 123(1) 177-187

38. Effects of interval between age at first pregnancy and age at diagnosis on breast cancer survival according to menopausal status: a register-based study in Korea. Lee, JungSun; Oh, Minkyung; Society, Korean Breast Cancer (Kang, Hee Joon). BMC women's health 2014 14(1) 113

39. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004. Ahn, Sei Hyun; Yoo, Keun Young; Society, Korean Breast Cancer (Kang, Hee Joon). Breast cancer research and treatment 2006 99(2) 209-214

40. Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996–2006) using nationwide breast cancer registration on‐line program: Biannual update. Ko, Seung Sang; Society, Korean Breast Cancer (Kang, Hee Joon). Journal of surgical oncology 2008 98(5) 318-323

41. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Han, Wonshik; Kang, So Young; Society, Korean Breast Cancer (Kang, Hee Joon). Breast cancer research and treatment 2010 119(1) 193-200

42. Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival. Lee, Jin-Hee; Yim, Seon-Hee; Won, Young-Joo; Jung, Kyu-Won; Son, Byung Ho; Lee, Hy-De; Lee, Eun-sook; Yoo, Keun-Young; Ahn, Sei Hyun; Shin, Hai-Rim; Society, Korean Breast Cancer (Kang, Hee Joon). Journal of Korean medical science 2007 22(Suppl) S11-S16

43. The Korean hereditary breast cancer (KOHBRA) study: protocol review. Kim, Eun-Kyu; Kim, Ku Sang; Park, Sue Kyung; Ahn, Sei-Hyun; Lee, Min Hyuk; Kim, Sung-Won; Society, Korean Breast Cancer (Kang, Hee Joon). Journal of Breast Cancer 2007 (10)4 241-247

44. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. Son, Byung Ho; Ahn, Sei Hyun; Kim, Sung-Won; Kang, Eunyoung; Park, Sue K; Lee, Min Hyuk; Noh, Woo-Chul; Kim, Lee Su; Jung, Yongsik; Kim, Ku Sang; Society, Korean Breast Cancer (Kang, Hee Joon). Breast cancer research and treatment 2012 133(3) 1143-1152

45. Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis. Lee, Eun-Ha; Park, Sue K; Park, Boyoung; Kim, Sung-Won; Lee, Min Hyuk; Ahn, Sei Hyun; Son, Byung Ho; Yoo, Keun-Young; Kang, Daehee; Group, KOHBRA Research; Society, Korean Breast Cancer (Kang, Hee Joon). Breast cancer research and treatment 2010 122(1) 11-25

46. Hereditary breast cancer in Korea: a review of the literature. Son, Byung Ho; Ahn, Sei Hyun; Lee, Min Hyuk; Park, Sue Kyung; Kim, Sung-Won; Society, Korean Breast Cancer (Kang, Hee Joon). Journal of Breast cancer 2008 11(1) 1-9

47. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study. Han, Sang-Ah; Kim, Sung-Won; Kang, Eunyoung; Park, Sue K; Ahn, Sei-Hyun; Lee, Min Hyuk; Nam, Seok-Jin; Han, Wonshik; Bae, Young Tae; Kim, Hyun-Ah; Society, Society, Korean Breast Cancer (Kang, Hee Joon). Familial cancer 2013 12(1) 75-81

48. Cost-effectiveness analysis of 5 years of postoperative adjuvant tamoxifen therapy for korean women with breast cancer: Retrospective cohort study of the korean breast cancer society database. Yang, Jae Jeong; Park, Sue K; Cho, Lisa Y; Han, Wonshik; Park, Boyoung; Kim, Hyeongsu; Lee, Kun-Sei; Hahn, Seo Kyung; Cho, Sung-il; Ahn, Sei-Hyun; Society, Korean Breast Cancer (Kang, Hee Joon). Clinical therapeutics 2010 32(6) 1122-1138

49. Immediate Breast Reconstruction Following Mastectomy for the Treatment of Advanced Breast Cancer Patients. Yoon, Ho Sung; Ko, Chang Dae; Kang, Hee Joon; Ahn, Sei Hyun; Lee, Taik Jong; Han, Sang Hoon. Journal of the Korean Surgical Society 2002 62(2) 127-132

50. Management of Cancer-Related Fatigue (CRF). Kim, Lee Su; Kang, Hee Joon. Korean Journal of Clinical Oncology 2007 3(1) 39-47

51. ChREBP regulates fructose-induced glucose production independently of insulin signaling. Mi-Sung Kim,1 Sarah A. Krawczyk,1 Ludivine Doridot,1 Alan J. Fowler,1 Jennifer X. Wang,2 Sunia A. Trauger,2 Hye-Lim Noh,3 Hee Joon Kang,3 John Meissen,4 Matthew Blatnik,4 Jason K. Kim,3 Michelle Lai,5 and Mark A. Herman1,6 J Clin Invest. 2016 126(11): 4372-4386.


Àú¼­/Àú¼ú
1. À¯¹æÇÐ Á¦2ÆÇ, Çѱ¹À¯¹æ¾ÏÇÐȸ, ÀÏÁ¶°¢ (°øµ¿ÀúÀÚ), 2007

2. À¯¹æ¾Ï ȯÀÚ¸¦ À§ÇÑ Ä¡·á¾È³»¼­ Á¦2ÆÇ, ¿µÃ¢ÀÇÇм­Àû (¾È¼¼Çö, ¼Õº´È£, °­ÈñÁØ ¿Ü), 2007

3. ¿Ü°úÇÐ Á¦1ÆÇ, ´ëÇÑ¿Ü°úÇÐȸ, ±ºÀÚÃâÆÇ»ç (°øµ¿ÀúÀÚ), 2011

4. ¿Ü°úÇÐ Á¦2ÆÇ, ´ëÇÑ¿Ü°úÇÐȸ, ±ºÀÚÃâÆÇ»ç (°øµ¿ÀúÀÚ). 2017